Journals / Atatürk Üniversitesi Tıp Dergisi (Y. A. The Eurasian Journal of Medicine) / 2001 / Cilt: 33 - Sayı: 2

Bartter's syndrome: A case report of nephrocalcinosis

Nefrokalsinozisli bir Bartter sendromu olgusu

Pages
57–59
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We reported a case of Barter's syndrome with nephrocalcinosis and discussed clinical significance of nephrocalcinosis in this syndrome.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Bartter's syndrome is characterized by generalized hyperplasia of juxtaglomerular apparatus, hyperreninism leading to secondary hyperaldesteronism, hypokalemic alkalosis and normal blood pressure.
📊
Key Findings & Data:Although nephrocalcinosis has been described sporadically in patients with Barter's syndrome, this is still generally unrecognized.
💡
Conclusion & Impact:We reported a case of Barter's syndrome with nephrocalcinosis and discussed clinical significance of nephrocalcinosis in this syndrome.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Bartter's syndrome is characterized by generalized hyperplasia of juxtaglomerular apparatus, hyperreninism leading to secondary hyperaldesteronism, hypokalemic alkalosis and normal blood pressure. Although nephrocalcinosis has been described sporadically in patients with Barter's syndrome, this is still generally unrecognized. We reported a case of Barter's syndrome with nephrocalcinosis and discussed clinical significance of nephrocalcinosis in this syndrome.

Özet

Bartter sendromu juxtaglomeruler aparatusun generalize hiperplazisi, sekonder hiperaldosteronizme sebep olan hiperreninizm, hipopotasemik alkaloz ve normal kan basıncı ile karakterize bir sendromdur. Bartter sendromlu hastalarda nefrokalsinozis sporadik olarak bildirilmekle birlikte, bu durum genellikle tanı almamaktadır. Kliniğimizde tanı konulan, nefrokalsinozisli bir Bartter sendromu olgusu takdim edilip bu bulgunun klinik önemi tartışıldı.

🔖

Cite This Article

KOŞAN, C. (2022). Bartter's syndrome: A case report of nephrocalcinosis. Atatürk Üniversitesi Tıp Dergisi (Y. A. The Eurasian Journal of Medicine), Cilt: 33 - Sayı: 2, 57–59. https://ajindex.com/articles/454845

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. W Proesmans. Bartter's syndrome and its neonatal variant. Eur J Pediatr 1997; 156: 669-679 2. Garel L, Filiatrault D, Robitaille P. Nephrocalcinosis in Bartter's syndrome. Pediatr Nephrol 1988;2:316-317 3. Houser M, Zimmerman B, Davidman M, et al. Idiopathic hypercalciuria associated with hyperreninemia and high urinary prostaglandin E. Kidney Int 1984;26:176-182 4. Yamada M, Matsumoto T, Takahashi N, et al. Stimulatory effect of prostaglandin E2 on 1- α 25-dihydroxyvitamin D3 synthesis in rats. Biochem J, 1983;216:237-240 5. Matsumoto J, Han BK, de Rovetto CR, et al. Hypercalciuric Bartter s syndrome: Resolution of nephrocalcinosis with indomethacin AJR 1989;152:1251-1253 6. Restrepo de Rovetto C, Welch TR, Hug G, et al. Hypercalciuria with Bartter's syndrome: evidence for an abnormality of vitamin D metabolism. J Pediatr 1989,115:397-404 7. Craig JC, Falk MC. Indomethacin for renal impairment in neonatal Bartter's syndrome. Lancet 1996; 347: 550 8. Betend B, David L. Treatment of hyperprostaglandin E syndrome with indomethacin. J Pediatr 1993; 123: 334 9. Cumming WA, Ohlsson A. Nephrocalcinosis in Bartter's syndrome demonstration by ultrasonography. Pediatr Radiol 1984; 14:125-126